First-in-human, phase I study of AK109, an anti-VEGFR2 antibody in patients with advanced or metastatic solid tumors
| Autor: | Zheng, Y., Zhong, H., Zhao, F., Zhou, H., Mao, C., Lv, W., Yuan, M., Qian, J., Jiang, H., Wang, Z., Xiao, C., Guo, J., Liu, T., Liu, W., Wang, Z.M., Li, B., Xia, M., Xu, N. |
|---|---|
| Zdroj: | In ESMO Open April 2023 8(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|